Shear-induced von Willebrand factor-mediated platelet surface translocation of the CD40 ligand

Thrombosis Research

Volumn 108, Issue 5-6, 2002, Pages 311-315

  Tamura, Noriko ^a   Yoshida, Minako ^a   Ichikawa, Noriko ^a   Handa, Makoto ^b   Ikeda, Yasuo ^b   Tanabe, Teruhisa ^a   Handa, Shunnosuke ^a   Goto, Shinya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD40 ligand; Platelet; Shear stress; Von Willebrand factor

Indexed keywords

ADRENALIN; CD40 LIGAND; GLYCOPROTEIN IB; IMMUNOGLOBULIN G; PADGEM PROTEIN; VON WILLEBRAND FACTOR; MONOCLONAL ANTIBODY; THROMBIN RECEPTOR;

ADRENALIN RELEASE; ADRENERGIC STIMULATION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; SHEAR STRESS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; ADULT; CELL MEMBRANE; CHEMISTRY; IMMUNOLOGY; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE;

ADULT; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; CD40 LIGAND; CELL MEMBRANE; EPINEPHRINE; FLOW CYTOMETRY; HUMANS; P-SELECTIN; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN TRANSPORT; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 0038506231     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00098-7     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
2. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
3. Hollenbaugh D., Mischel-Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A.et al. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:1995;33-40.
4. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U. S. A. 92:1995;4342-4346.
5. Mach F., Schobeck U., Sukhova G.K., Bourcier T., Bonnefoy J.Y., Pober J.S.et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1931-1936.
6. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G.et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 391:1998;591-594.
7. Goto S. Role of von Willebrand Factor for the onset of arterial thrombosis. Clin. Lab. 47:2001;327-334.
8. Schobeck U., Mach F., Sukhova G.K., Atkinson E., Levesque E., Herman M. et al. Expression of stromelysin-3 in athero-sclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J. Exp. Med. 189:1999;843-853.
9. Phillips R.P. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6930-6932.
10. Ikeda Y., Handa M., Kamata T., Kawano K., Kawai Y., Watanabe K.et al. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb. Haemost. 69:1993;496-502.
11. Goto S., Eto K., Ikeda Y., Handa S. Abciximab not RGD peptide inhibits von Willebrand factor-dependent platelet activation under shear. Lancet. 353:1999;809. [research letter].
12. Goto S., Salomon D.R., Ikeda Y., Ruggeri Z.M. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand Factor to platelets. J. Biol. Chem. 270:1995;23352-23361.
13. Goto S., Ichikawa N., Li M.et al. Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow. Int. Angiol. 19:2000;147-151.
14. Kroll M.H., Hellums J.D., McIntire L.V., Schafer A.I., Moake J.L. Platelets and shear stress. Blood. 88:1996;1525-1541.
15. Goto S., Tamura N., Handa S., Arai M., Kodama K., Takayama H. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation. 106:2002;266-272.
16. Goto S., Tamura N., Handa S. Effects of adenosine 5′-diphosphate (ADP) receptor blockade on platelet aggregation under flow. Blood. 99:2002;4644-4645.
17. Savage B., Almus-Jacobs F., Ruggeri Z.M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 94:1998;657-666.
18. Ruggeri Z.M., Dent J.A., Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 94:1999;172-178.
19. Goto S., Ikeda Y., Saldivar E., Ruggeri Z.M. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow condition. J. Clin. Invest. 101:1998;479-486.
20. Ikeda Y., Handa M., Kawano K., Kamata T., Murata M., Araki Y.et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87:1991;1234-1240.
21. Goto S., Ikeda Y., Murata M., Handa M., Takahashi E., Yoshioka A.et al. Epinephrine augments von Willebrand factor dependent shear-induced platelet aggregation. Circulation. 86:1992;1859-1863.
22. Brams P., Black A., Padlan E.A., Hariharan K., Leonard J., Chambers-Slater K.et al. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. Int. Immunopharmacol. 1:2001;277-294.
23. Katayama M., Handa M., Ambo H., Araki Y., Hirai S., Kato I.et al. A monoclonal antibody-based enzyme immunoassay for human GMP-140/P-selectin. J. Immunol. Methods. 153:1992;41-48.
24. Fujimura Y., Usami Y., Titani K., Niinomi K., Nishio K., Takase T.et al. Nucleotide, protein studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin-and botrocetin-induced vWF binding to platelet glycoprotein Ib. Blood. 77:1991;113-120.
25. Henn V., Steinbach S., Buchner K., Presek P., Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by co-expressed CD40. Blood. 98:2001;1047-1054.
26. Bellinger D.A., Nichols T.C., Read M.S., Reddick R.L., Lamb M.A., Brinkhous K.M.et al. Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor. Proc. Natl. Acad. Sci. U. S. A. 84:1987;8100-8104.
27. Yao S.K., Ober J.C., Garfinkel L.I.et al. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronarythrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation. 89:1994;2822-2828.
28. Ruggeri Z.M., Ware J. von Willebrand factor. FASEB J. 7:1993;308-316.
29. Back C.H., Radbill J.R., Crawford D.W. Analysis of pulsatile viscous blood flow through diseased coronary arteries of man. J. Biomech. 10:1977;339-353.
30. Scharf R.E., Tomer A., Marzec U.M., Teirstein P.S., Ruggeri Z.M., Harker L.A. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler. Thromb. 12:1992;1475-1487.
31. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:1986;131-138.
32. Stemme S., Rymo L., Hansson G.K. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65:1991;654-660.
33. Swanson S.J., Rosenzweig A., Seidman J.G., Libby P. Diversity of T-cell antigen receptor V gene utilization in advanced human atheroma. Arterioscler. Thromb. 14:1994;1210-1214.
34. Cocks B.G., de Waal Malefyt R., Galizzi J.P., de Vries J.E., Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 5:1993;657-663.